These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23804751)

  • 1. IGF-1 receptor antagonism inhibits autophagy.
    Renna M; Bento CF; Fleming A; Menzies FM; Siddiqi FH; Ravikumar B; Puri C; Garcia-Arencibia M; Sadiq O; Corrochano S; Carter S; Brown SD; Acevedo-Arozena A; Rubinsztein DC
    Hum Mol Genet; 2013 Nov; 22(22):4528-44. PubMed ID: 23804751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.
    Damerill I; Biggar KK; Abu Shehab M; Li SS; Jansson T; Gupta MB
    Mol Endocrinol; 2016 Feb; 30(2):201-16. PubMed ID: 26714229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-214 Reduces Insulin-like Growth Factor-1 (IGF-1) Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells.
    Das F; Dey N; Bera A; Kasinath BS; Ghosh-Choudhury N; Choudhury GG
    J Biol Chem; 2016 Jul; 291(28):14662-76. PubMed ID: 27226530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-1 inhibits MPTP/MPP
    Wang XW; Yuan LJ; Yang Y; Zhang M; Chen WF
    Am J Physiol Endocrinol Metab; 2020 Oct; 319(4):E734-E743. PubMed ID: 32865008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion.
    Zhou J; Tan SH; Nicolas V; Bauvy C; Yang ND; Zhang J; Xue Y; Codogno P; Shen HM
    Cell Res; 2013 Apr; 23(4):508-23. PubMed ID: 23337583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
    Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
    Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options.
    Quesada AE; Nguyen ND; Rios A; Brown RE
    Int J Clin Exp Pathol; 2014; 7(12):8732-9. PubMed ID: 25674239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling.
    Ding M; Bruick RK; Yu Y
    Nat Cell Biol; 2016 Mar; 18(3):319-27. PubMed ID: 26854565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.
    Balgi AD; Fonseca BD; Donohue E; Tsang TC; Lajoie P; Proud CG; Nabi IR; Roberge M
    PLoS One; 2009 Sep; 4(9):e7124. PubMed ID: 19771169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.
    Sharon C; Baranwal S; Patel NJ; Rodriguez-Agudo D; Pandak WM; Majumdar AP; Krystal G; Patel BB
    Oncotarget; 2015 Jun; 6(17):15332-47. PubMed ID: 25895029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTORC2 phosphorylates protein kinase Cζ to regulate its stability and activity.
    Li X; Gao T
    EMBO Rep; 2014 Feb; 15(2):191-8. PubMed ID: 24375676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupting IGF Signaling in Adult Mice Conditions Leanness, Resilient Energy Metabolism, and High Growth Hormone Pulses.
    François JC; Aïd S; Chaker Z; Lacube P; Xu J; Fayad R; Côté F; Even P; Holzenberger M
    Endocrinology; 2017 Jul; 158(7):2269-2283. PubMed ID: 28881863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets.
    Moore SF; Hunter RW; Hers I
    J Thromb Haemost; 2014 May; 12(5):748-60. PubMed ID: 24612393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The luteinizing hormone-releasing hormone inhibits the anti-apoptotic activity of insulin-like growth factor-1 in pituitary alphaT3 cells by protein kinase Calpha-mediated negative regulation of Akt.
    Rose A; Froment P; Perrot V; Quon MJ; LeRoith D; Dupont J
    J Biol Chem; 2004 Dec; 279(50):52500-16. PubMed ID: 15448167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-199a-3p is involved in estrogen-mediated autophagy through the IGF-1/mTOR pathway in osteocyte-like MLO-Y4 cells.
    Fu J; Hao L; Tian Y; Liu Y; Gu Y; Wu J
    J Cell Physiol; 2018 Mar; 233(3):2292-2303. PubMed ID: 28708244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual IGF-I/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growth.
    Gao J; Chesebrough JW; Cartlidge SA; Ricketts SA; Incognito L; Veldman-Jones M; Blakey DC; Tabrizi M; Jallal B; Trail PA; Coats S; Bosslet K; Chang YS
    Cancer Res; 2011 Feb; 71(3):1029-40. PubMed ID: 21245093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target.
    Herrero-Martín D; Osuna D; Ordóñez JL; Sevillano V; Martins AS; Mackintosh C; Campos M; Madoz-Gúrpide J; Otero-Motta AP; Caballero G; Amaral AT; Wai DH; Braun Y; Eisenacher M; Schaefer KL; Poremba C; de Alava E
    Br J Cancer; 2009 Jul; 101(1):80-90. PubMed ID: 19491900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade.
    Shi Y; Yan H; Frost P; Gera J; Lichtenstein A
    Mol Cancer Ther; 2005 Oct; 4(10):1533-40. PubMed ID: 16227402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of lysosomes activates the MTORC1 signaling pathway in chondrocytes in an autophagy-independent manner.
    Newton PT; Vuppalapati KK; Bouderlique T; Chagin AS
    Autophagy; 2015; 11(9):1594-607. PubMed ID: 26259639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.